Patents Assigned to VAPOMED LIMITED
  • Publication number: 20170100333
    Abstract: The invention relates to a system for the sequential intranasal administration of at least one active ingredient selected from a DR group having at least one side effect of respiratory depression and at least one active ingredient selected from an ADR group that counteracts the respiratory depression that may be induced by the active ingredients of the DR group. The invention also relates to a portable sequential intranasal administration device comprising an intranasal administration system according to the principles of the invention.
    Type: Application
    Filed: February 8, 2016
    Publication date: April 13, 2017
    Applicant: VAPOMED LIMITED
    Inventors: Jacques SEGUIN, Emad SABRY